IMUX vs MSFT: Which Stock is Better?
Side-by-side comparison of Immunic Inc and Microsoft Corp in 2026
IMUX
Immunic Inc
$1.11
MSFT
Microsoft Corp
$419.69
Key Metrics Comparison
| Metric | IMUX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $153.95M | N/A | IMUX |
| P/E Ratio | N/A | 24.57 | MSFT |
| EPS (TTM) | $N/A | $16.00 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze IMUX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMUX or MSFT a better investment?
Comparing IMUX and MSFT: Immunic Inc has a market cap of $153.95M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMUX and MSFT?
IMUX (Immunic Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMUX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMUX or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for IMUX.
Which company is more profitable: IMUX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for IMUX.
Which is the larger company: IMUX or MSFT?
Immunic Inc (IMUX) is larger with a market cap of $153.95M compared to N/A for MSFT.
Should I buy IMUX or MSFT in 2026?
Both IMUX and MSFT have investment merit. IMUX trades at $1.11 while MSFT trades at $419.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMUX and MSFT stock?
Key differences: Market Cap ($153.95M vs N/A), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).